Literature DB >> 22006422

Association of ApoE genetic polymorphisms with proximal deep venous thrombosis.

Luís Cavalcante Nagato1, Marcela Augusta de Souza Pinhel, José Maria Pereira de Godoy, Dorotéia Rossi Silva Souza.   

Abstract

The aim of the current study was to evaluate a possible association between apolipoprotein E (ApoE) genetic polymorphisms and deep venous thrombosis. A case-control study of ApoE genetic polymorphisms was carried out in 60 male and female patients with deep venous thrombosis and 60 male and female controls. The ages of the patients ranged between 23 and 90 years old (mean ± standard deviation: 58 ± 16.56 years) and the ages of the control group, varied between 21 and 56 years old (mean ± SD: 33 ± 10.93 years). Genetic polymorphisms were analyzed in respect to the prevalence of alleles (APOE*2, APOE*3 and APOE*4) and genotypes (APOE*2/2, APOE*2/3, APOE*2/4, APOE*3/3, APOE*3/4 and APOE*4/4). The ε2 allele was more common in patients who had suffered thrombotic events (P = 0.0034). Additionally, there was a significant difference on comparing the distribution of alleles in female patients and female controls (P = 0.027). These results demonstrate an association between the ApoE ε2 allele and deep venous thrombotic events in women. This association opens the possibility of a new line of research to better understand these thrombotic events.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22006422     DOI: 10.1007/s11239-011-0639-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  8 in total

1.  Warfarin dose related to apolipoprotein E (APOE) genotype.

Authors:  Hugo Kohnke; Kristina Sörlin; Göran Granath; Mia Wadelius
Journal:  Eur J Clin Pharmacol       Date:  2005-06-11       Impact factor: 2.953

2.  Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.

Authors:  O Olivieri; N Martinelli; D Girelli; F Pizzolo; S Friso; F Beltrame; V Lotto; L Annarumma; R Corrocher
Journal:  J Thromb Haemost       Date:  2009-12-11       Impact factor: 5.824

3.  Assignment of the human antithrombin III structural gene to chromosome 1q23-25.

Authors:  S C Bock; J F Harris; I Balazs; J M Trent
Journal:  Cytogenet Cell Genet       Date:  1985

4.  Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis.

Authors:  Jason O Robertson; Wei Li; Roy L Silverstein; Eric J Topol; Jonathan D Smith
Journal:  Thromb Res       Date:  2008-08-15       Impact factor: 3.944

5.  The association of Apoprotein E polymorphisms with recurrent pregnancy loss.

Authors:  Chelsi Goodman; Cyle S Goodman; Jee Hur; R S Jeyendran; Carolyn Coulam
Journal:  Am J Reprod Immunol       Date:  2009-01       Impact factor: 3.886

6.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  APOE genotyping: comparison of three methods.

Authors:  B H Rihn; S Berrahmoune; S Berahmoune; M Jouma; S Chamaa; L Marcocci; A Le Faou
Journal:  Clin Exp Med       Date:  2008-10-09       Impact factor: 3.984

8.  Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.

Authors:  Cláudia N Ferreira; Maria G Carvalho; Ana P S M Fernandes; Luciana M Lima; Andréia A Loures-Valle; Julizar Dantas; Zoltán Janka; András Palotás; Marinez O Sousa
Journal:  Neurochem Int       Date:  2009-10-09       Impact factor: 3.921

  8 in total
  3 in total

Review 1.  Rare thrombophilic conditions.

Authors:  Gian Luca Salvagno; Chiara Pavan; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

2.  Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation.

Authors:  Shuangli Zhu; ZhiGang Wang; XiaoPing Wu; Yan Shu; DunXiang Lu
Journal:  Lipids Health Dis       Date:  2014-01-24       Impact factor: 3.876

3.  Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy.

Authors:  Yassene Mohammed; Carolina E Touw; Banne Nemeth; Raymond A van Adrichem; Christoph H Borchers; Frits R Rosendaal; Bart J van Vlijmen; Suzanne C Cannegieter
Journal:  J Thromb Haemost       Date:  2022-01-06       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.